Figure 10.
Recurrence and safety of fecal microbiota transplantation in the treatment of various diseases. 95% CI, 95% confidence interval; RCDI, recurrent Clostridioides difficile infection; IBD, inflammatory bowel disease; UC, ulcerative colitis; AUC, active UC; CD, Crohn’s disease; AMR, antimicrobial resistance; IBS, irritable bowel syndrome; CDAD, Clostridioides difficile-associated diarrhea; GVHD, graft versus host disease; RCTs, randomized clinical trials; SATs, single-arm trials; NR, not reported; NA, not applicable.